Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Store
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Shaina D. Barnes, Pharm D: Isolated Aripiprazole Drug Interaction with Estrogen
$
30.00
Add to cart
Details
Carol Vidal Castro, MD – Reboxetine: An Alternative for Induced Bruxism
$
30.00
Add to cart
Details
Michael E. Thase, MD: Editor’s Letter
$
0.00
Add to cart
Details
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
$
30.00
Add to cart
Details
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
$
30.00
Add to cart
Details
Takefumi Suzuki, MD, PhD: A Potentially Aborted Neuroleptic Malignant Syndrome Following Seclusion Against Uncontrollable Water Intoxication
$
30.00
Add to cart
Details
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
$
30.00
Add to cart
Details
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
$
30.00
Add to cart
Details
Sumeet Roy, PhD, MBA: Efficacy of Print Advertising for a Bipolar Disorder Study
$
30.00
Add to cart
Details
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
$
30.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Indira Varia, MD: Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Claus Rosenberg, MD: Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice
$
30.00
Add to cart
Details
Placebo Response in Depression: A Perspective for Clinical Practice
$
30.00
Add to cart
Details
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials
$
30.00
Add to cart
Details
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
$
30.00
Add to cart
Details
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
$
30.00
Add to cart
Details
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
$
30.00
Add to cart
Details
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
$
30.00
Add to cart
Details
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
$
30.00
Add to cart
Details
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
$
30.00
Add to cart
Details
Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
$
0.00
Add to cart
Details
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY: AUTHOR REPLY
$
0.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
$
30.00
Add to cart
Details
Hypomania Induced by Escitalopram: 2 Case Reports
$
30.00
Add to cart
Details
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
$
30.00
Add to cart
Details
Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
$
30.00
Add to cart
Details
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
$
30.00
Add to cart
Details
Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
$
30.00
Add to cart
Details
Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report
$
30.00
Add to cart
Details
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
$
30.00
Add to cart
Details
Antidepressant Induced Apathy Responsive to Dose Reduction
$
30.00
Add to cart
Details
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
$
30.00
Add to cart
Details
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
Previous
1
…
11
12
13
…
22
Next
Page load link
Go to Top
